CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

Oncology NEWS International. Vol. 18 No. 5
News & Analysis 

ASCO draws road map to navigate economic, racial disparities in ca care

By Fran Lowry | May 22, 2009
The incidence of cancer is projected to surge in the U.S. as community leaders address the “profound divide” between those who have access to healthcare and those who don’t.

ASCO has issued policy recommendations designed to eliminate existing disparities between minorities and whites, and between those with and without health insurance. “Disparities in Cancer Care” comes as the incidence of cancer is projected to increase significantly in the next 20 years, a situation that could be catastrophic if not dealt with sooner rather than later.

“We have fought so hard to make really important gains in the fight against cancer and have started to see improvements in cure rates in many areas,” said Derek Raghavan, MD, PhD, cochair of ASCO’s Health Disparities Group. “We will see that slip from our grasp if we don’t function as a society to provide adequate current and appropriate healthcare for people who are somewhat disadvantaged, either financially, geographically, or by cultural impediments.”

Equal access
“Advances in cancer research have led to the development of sophisticated screening and treatment methods thereby contributing to substantial improvements in survival rates,” said Richard L. Schilsky, MD, ASCO president.

“However, there continues to be a profound divide in our nation between those with access to the improved results of our research efforts and those without access,” added Dr. Schilsky, who is a professor of medicine at the University of Chicago Medical Center.

Dr. Raghavan outlined the components of the ASCO statement, which calls for increased efforts in the following areas:

• Research into the differences in quality of care provided to minorities vs whites

• Research on the factors contributing to poorer quality of care

• Enrollment of minorities in clinical trials

• Diversity of the oncology workforce to provide more culturally appropriate care

• Encouragement for oncologists to practice in underserved areas

• Development of policies to guarantee equal access to quality healthcare, with an emphasis on insurance coverage and reduced economic barriers to cancer care

“Developing policies to guarantee equal access to quality healthcare is a critical factor. Lack of insurance is a huge barrier to improving cancer care and survival in the U.S.,” commented Dr. Raghavan, who is the chair and director of Taussig Cancer Center at the Cleveland Clinic.

“A reformed system should ensure comprehensive, coordinated treatment for people living with cancer and eliminate barriers to important screening services that allow us to detect cancers earlier and prevent recurrence and, thus, improve outcomes,” he said.


The total number of cancers diagnosed in the U.S. will increase by 45% in the next two decades, from 1.6 million cancers to 2.3 million cancers, said Benjamin D. Smith, MD, chief of radiation oncology at Wilford Hall Medical Center at the Lackland Air Force Base in San Antonio.

Dr. Smith studied demographic trends using the SEER database and population projections from the U.S. census bureau to estimate the total number of cancers that will be diagnosed in the U.S. from 2010 to 2030. His coinvestigators are from Houston’s M.D. Anderson Cancer Center and the City of Hope Cancer Center in Duarte, Calif.

This increase will be driven by new cancers in adults over the age of 65 and in minorities, Dr. Smith said (see Table). The total number of cancers diagnosed in older adults will increase by 67%, from 1 million to 1.6 million, and the total number of cancers diagnosed in minorities will increase by 100%, from 330,000 to 660,000 (J Clin Oncol online, April 29, 2009). “Our results highlight the urgency of addressing shortcomings in the cancer care received by older adults and minorities,” Dr. Smith said.

Dr. Raghavan called these statistics “very strong and inescapable. Although we may not quite reach the cancer figures projected by Dr. Smith and colleagues, we’ve known for a long time that we would have an emerging group of aging baby boomers.”

“We also know that the population of minorities in this country has increased, and that there are increasing problems that relate to unemployment and lack of health insurance,” he added. Visit www.asco.org for resources on health disparities, such as educational opportunities, avenues of research, and relevant publications.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 

 
PUBLICATIONS
ONCOLOGY Journal ONCOLOGY Nurse Edition Journal Cancer Management: A Multidisciplinary Approach

ONCOLOGY:
Perspectives on Best Practices

ONCOLOGY:
Nurse Edition

CANCER
MANAGEMENT
:
A Multidisciplinary
Approach


 
IMAGE IQ

Other than surgical interventions, which medication might be most appropriate for this patient?

A 68-year-old woman presented with a mass on the scalp. An incisional biopsy of the scalp mass and an excisional biopsy of the lymph node both revealed basal cell carcinoma.

 

More Image IQs:

 

 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Head and Neck Tumors
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs



CancerNetwork on Facebook

 

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy